211 related articles for article (PubMed ID: 5279364)
1. [Treatment of chronic myeloid leukemia with dibromomannitol].
Clément F; Saillen R
Schweiz Med Wochenschr; 1970 Nov; 100(46):1995-7. PubMed ID: 5279364
[No Abstract] [Full Text] [Related]
2. Chronic myeloid leukaemia: course, life expectancy, and an analysis of dibromomannitol and busulfan treatment.
Gerhartz H
Haematologica; 1972 Apr; 57(11):775-86. PubMed ID: 4200312
[No Abstract] [Full Text] [Related]
3. Chemotherapy of chronic myelocytic leukemia.
Galton DA
Semin Hematol; 1969 Oct; 6(4):323-43. PubMed ID: 4900650
[No Abstract] [Full Text] [Related]
4. [Treatment of chronic myeloid leukemia with Dibromomannitol].
Saillen R; Clément F
Schweiz Rundsch Med Prax; 1970 Sep; 59(38):1325-33. PubMed ID: 5283076
[No Abstract] [Full Text] [Related]
5. [Treatment of chronic myelogenous leukemia with oral dibromomannitol (author's transl)].
Kawashima K; Kotera Y; Nagata K; Ueda R; Yoshikawa H
Rinsho Ketsueki; 1973 Sep; 14(9):931-4. PubMed ID: 4519905
[No Abstract] [Full Text] [Related]
6. [Results of cytostatic and radiologic treatment of chronic myelocytic leukemia (analysis of 11 cases)].
Maurice PA
Rev Med Suisse Romande; 1970 Jun; 90(6):521-32. PubMed ID: 5293581
[No Abstract] [Full Text] [Related]
7. Results in the treatment of chronic myeloid leukaemia.
Nasr AL; Aboul-Enein M; Tawfik HN
Haematologica; 1972 Apr; 57(11):794-802. PubMed ID: 4200314
[No Abstract] [Full Text] [Related]
8. [Preliminary results of myelobromol treatment of chronic granulocytic leukemia].
Urasiński I; Mysik M
Wiad Lek; 1971 Jul; 24(3):271-4. PubMed ID: 5279032
[No Abstract] [Full Text] [Related]
9. Dibromomannitol and chronic myeloid leukaemia results of a cooperative study.
Haematologica; 1972 Apr; 57(11):732-40. PubMed ID: 4200308
[No Abstract] [Full Text] [Related]
10. [Trial treatment of chronic myeloid leukemia with 3 new chemotherapeutic agents: dibromomannitol, hydroxyurea and desacetamidocolchicine].
Cattan A; Schneider M; Schwarzenberg L; Amiel JJ; Schlumberger JR; Gluckman E; Mathé G
Sem Hop; 1966 Nov; 42(49):2966-9. PubMed ID: 4292624
[No Abstract] [Full Text] [Related]
11. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
Larrain C; Cruz A; Codoceo V
Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227
[No Abstract] [Full Text] [Related]
12. Survival of chronic myeloid leukaemia patients treated by dibromomannitol.
Eur J Cancer (1965); 1973 Aug; 9(8):583-9. PubMed ID: 4596582
[No Abstract] [Full Text] [Related]
13. [Survival of 29 cases of chronic myeloid leukemia treated by myleran].
Petitclerc C; Barry A
Union Med Can; 1976 Feb; 105(2):210-6. PubMed ID: 1069396
[No Abstract] [Full Text] [Related]
14. Dibromomannitol (NSC-94100): a clinical study of previously treated patients with refractory chronic myelocytic leukemia and blastic transformation.
Levin WC; Mims CH; Haut A
Cancer Chemother Rep; 1974; 58(2):223-8. PubMed ID: 4598242
[No Abstract] [Full Text] [Related]
15. [Chronic myelogenous leukemia. Results of therapy with busulfan].
Olesen J; Videbaek A
Nord Med; 1969 Oct; 82(41):1284-90. PubMed ID: 5260856
[No Abstract] [Full Text] [Related]
16. Treatment of myeloproliferative diseases.
Sellei C
Ther Hung; 1966; 14(4):135-6. PubMed ID: 5228101
[No Abstract] [Full Text] [Related]
17. A comparative study of dibromomannitol and busulfan in the treatment of chronic myeloid leukemia. A study of cancer and leukemia group B.
Silver RT; Mick R; Cooper R; Ellison RR; Levy R; Brunner K; Schwartz JM; Holland JF
Cancer; 1987 Oct; 60(7):1442-8. PubMed ID: 3113712
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy of leukemia patients with Myelobromol].
Staeuber PG; Gerhartz H; Liss E
Verh Dtsch Ges Inn Med; 1965; 71():733-7. PubMed ID: 5877696
[No Abstract] [Full Text] [Related]
19. [Reversible pituitary-adrenal insufficiency produced by busulfan].
García-San Miguel J; Pujol-Moix N
Rev Clin Esp; 1968 Sep; 110(5):467-72. PubMed ID: 4247382
[No Abstract] [Full Text] [Related]
20. [Therapeutic considerations in chronic myeloid leukemia].
Hunstein W
Med Klin; 1974 Mar; 69(10):412-6. PubMed ID: 4598268
[No Abstract] [Full Text] [Related]
[Next] [New Search]
